You are here: Industry Insights > drug development

News List

From Molecule to Market: Innovations Accelerating the Future of Drug Development Annie Roys
September 04, 2025
Drug discovery and development has historically been a lengthy, high risk, and costly process, often spanning more than a decade and consuming billions of dollars before a product reaches patients.
Strategies to Facilitating Accelerated Drug Development Muhammad Asim Niazi
February 17, 2025
The article details FDA's Accelerated Drug Development, including guidelines, definition of serious conditions, strategies, features, and withdrawal reasons.
How to Choose a Small-molecule Drug Substance Partner Saher Haider
August 02, 2024
In this article, we will specifically focus on criteria for selecting a small-molecule drug substance partner.
New Drugs for Old: Repurposing and Repositioning Pharmaceuticals Suzanne Elvidge
July 15, 2024
Drug repurposing and repositioning offers a cost effective and efficient route to the market that allows patients to get access to drugs more quickly.
Overview of New "Don't Eat Me" Target CD24 Research Zhaoruijie/PharmaSources
July 03, 2023
Recently, Antengene Corporation announced that the Phase I clinical trial application (IND) of its global first anti-CD24 monoclonal antibody, ATG-031, had been approved by FDA.
Development of Anticancer Drugs for Ferroptosis: An Analysis of Representative Natural Products PharmaSources/Yuntian
May 08, 2021
Over the past years, anticancer strategies based on ferroptosis have been well acknowledged, leading to a boom in the development of anticancer drugs at home and abroad.
Alternative Method to Accelerate Drug Development Lin Zhang
January 21, 2021
Drug development is an essential process in the pharmaceutical industry, however, it is also time-consuming and costly which contains preclinical, clinical and after-market.
Pharma and Health from Ingredients to Pills: Artificial Intelligence (AI) and Drug Development Lin Zhang
December 09, 2020
Artificial Intelligence (AI) is gaining traction across a variety of sectors. AI can be used for a variety of goals and is likely to become a staple in drug development, among other things.
Advantages to Using CROs Lin Zhang
November 12, 2020
Today, contract research organizations (CROs) provide crucial services for almost any point along the drug pipeline.
Vetter Wins Best Managed Companies Award 2024 PharmaSources
May 30, 2024
Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), has once again been awarded the Best Managed Companies Award, marking its fifth consecutive win.